European Pharmaceutical Review

SEPTEMBER 26, 2022

Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. A three-year employee training programme, backed by the government and the IDA (a funding support agency), will help its 150 employees develop essential skills when using innovative, upcoming technologies. AbbVie announces Michael Severino, M.D.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

Spotio

JUNE 6, 2022

Outside Sales Reps Now Spend 89% More Time Selling Remotely Than in 2013. Sales Prospecting Statistics The way companies prospect for leads is changing. HubSpot] 9 in 10 companies use 2+ lead enrichment tools to learn more about prospects. Face to face or field sales teams make up 71.2% of the sales force.

Sales 111

Sales Prospecting B2B Sales Leads 111

pharmaphorum

JANUARY 3, 2023

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.

Side effects 52

Side effects Medicine Safety Healthcare 52

PM360

OCTOBER 22, 2024

For instance, one study found that from 1993 to 2013, only 5% of all clinical trials in respiratory diseases included members of racial or ethnic minority groups. While this wisdom of experience is highly valuable, it’s also highly subjective based on the provider’s individual training, experience, care setting, and patient population.

Side effects 52

Side effects Patients Prescription Healthcare 52

European Pharmaceutical Review

JANUARY 16, 2023

Innovation will be driven by an adequate supply of scientifically trained graduates from our universities and technical institutions with the appropriate on-the-job training.” Prior to November 2013 he worked for Merck Research Laboratories in Summit, New Jersey as the Senior Principal Scientist in early phase drug development.

Pharmaceutical 128

Pharmaceutical Food and Drug Administration Manufacturing Medicine 128

European Pharmaceutical Review

NOVEMBER 30, 2023

“Programmes available to industries are a little bit and diverse and convoluted, and Catapult is [hoping] to look at ways [to] simplify the process and provide access easy access to various skills trainings programmes.” From January 2013, Stephen was Cell and Gene Therapy Catapult’s founding Chief Operating Officer.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

pharmaphorum

SEPTEMBER 29, 2022

This can contribute to a scattergun approach in which findings are not collated, leading to duplicated efforts that waste time and resources for organisations, PAGs, and patients alike. This model allows for specialist patient engagement and centricity training and knowledge, which has a wealth of benefits.

Patients 88

Patients Food and Drug Administration Medicine Pharma 88